Published by ChinaMNC · yunnan
Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: What Foreign Founders Need to Know
Yunnan province has outlined a new plan for its traditional Chinese medicine materials industry through 2030, focusing on quality, processing, and branding. This article summarizes the key points from the official government notice, providing practical guidance for foreign founders looking to register or operate a company in China's TCM sector.
Yunnan's New TCM Materials Plan: Key Takeaways for Foreign Founders
Foreign founders considering entering China's traditional Chinese medicine (TCM) sector should pay attention to provincial development plans, which often signal regulatory priorities and market opportunities. Yunnan Province, a major producer of TCM materials, recently released its 15th Five-Year Plan for the Development of the Traditional Chinese Medicine Materials Industry. The plan, published on the Yunnan Provincial Government website, sets targets and outlines strategies through 2030. Below is a summary of the key points from the official interpretation, focusing on what matters for foreign founders.
Overall Targets: Fewer Acres, Higher Value
The plan aims to reduce the area dedicated to TCM material cultivation by 1.608 million mu (approximately 107,200 hectares) by 2030, while increasing the comprehensive output value by 50 billion yuan. This reflects a shift from quantity to quality: the goal is to exchange a reduction in area for improvements in quality, processing, branding, and efficiency. For foreign founders, this suggests that Yunnan will prioritize high-quality production over expansion, potentially creating opportunities in premium products and advanced processing.
Optimizing Variety Layout: What to Grow
Building on the 156 varieties listed in the Yunnan Catalogue of Authentic Medicinal Materials (2024 Edition), the plan focuses on three categories:
- Authentic advantageous varieties, such as the "Top Ten Yunnan Medicines" represented by Panax notoginseng (sanqi). The Top Ten Yunnan Medicines are: Panax notoginseng, Yunnan Paris polyphylla (dianchonglou), Erigeron breviscapus (dengzhanhua), Dendrobium officinale (tiepishihu), Amomum villosum (sharen), Gastrodia elata (tianma), Yunnan Poria (yunfuling), Yunnan Angelica sinensis (yundanggui), Yunnan Aucklandia lappa (yunmuxiang), and Yunnan Gentiana (yundanlong).
- Health-characteristic varieties, mainly the "Top Ten Health Resources": Yunnan Polygonatum kingianum (dianhuangjing), safflower (honghua), Bletilla striata (baiji), Dendrobium officinale (purple-skinned), Phyllanthus emblica (yuganzi or dian'ganlan), Coix seed (yiyiren), Terminalia chebula (hezi), Amomum tsaoko (caoguo), ginger (jiang), and star anise (bajiao).
- Potential cultivation varieties, represented by the "Six Southern Medicines": Amomum villosum (sharen), Dragon's blood (longxuejie), Cibotium barometz (gouji), agarwood (chenxiang), Orthosiphon aristatus (shencha), and Dai Bai Jie (dai bai jie).
Foreign founders should note that these categories indicate which TCM materials Yunnan will prioritize, guiding investment and sourcing decisions.
Accelerating Standardized Construction: How to Grow
The plan aims to establish 200 GAP (Good Agricultural Practice) bases for TCM materials. Key initiatives include:
- Full coverage of GAP bases for Wenshan Panax notoginseng.
- Orderly development of GAP bases for under-forest varieties such as Poria (fuling), Amomum villosum (sharen), Amomum tsaoko (caoguo), and Phellodendron chinense (huangbo).
- Striving to create a number of national-level high-standard TCM material raw material production bases.
GAP certification is important for foreign companies seeking to source high-quality materials or establish production facilities, as it ensures adherence to standardized practices.
Under-Forest Cultivation: Where to Grow
Focusing on authentic medicinal materials such as Panax notoginseng, Gastrodia elata (tianma), Poria (fuling), Amomum villosum (sharen), Polygonatum (huangjing), and Phellodendron (huangbo), the plan promotes under-forest cultivation and breeding. The goal is to expand ecological and under-forest planting bases to over 6 million mu. This approach may offer sustainable sourcing options and align with global trends toward eco-friendly production.
Primary Processing at Origin: How to Handle Harvested Materials
The plan supports establishing primary processing lines in authentic medicinal material production areas and high-standard raw material bases. It encourages linking GAP base materials with fresh-cut processing and upgrading products from primary raw materials to semi-industrialized input materials. For foreign founders, this signals opportunities in processing technology and equipment, as well as in supplying processed materials to downstream industries.
Developing High-Value-Added Products: How to Increase Returns
Enterprises are encouraged to build modern deep-processing production lines and develop high-value-added products, creating a series of Yunnan medicine health products. The plan also promotes research, development, and industrialization of health products such as daily chemical and beauty products, and functional health products. Foreign founders with expertise in these areas may find partnership or investment opportunities.
Preventing "Blind Expansion": How to Stabilize the Market
For bulk varieties susceptible to market fluctuations and scarce varieties—such as Panax notoginseng, Angelica sinensis (danggui), and Paris polyphylla (chonglou)—the plan emphasizes market-based adjustment to smooth price volatility. It also calls for building an information monitoring and early-warning system to guard against risks like "blind expansion" and "low prices hurting farmers." This indicates a more regulated market environment, which can benefit foreign companies relying on stable supply chains.
Food-Medicine Homology Development: New Uses for Medicinal Materials
The plan includes developing standards for food-medicine homologous raw materials, production and processing specifications, and completing cross-border registration of 5–10 new products. It also plans to organize a "Yunnan Medicine Food-Medicine Homology Cultural Festival." Food-medicine homology is a concept in TCM where certain ingredients are used both as food and medicine. Foreign founders should note that cross-border registration may open opportunities for imported products, but compliance with Chinese standards is essential.
"Yunnan Medicine Brain": How to Be Smarter
The plan implements the "Yunnan Medicine Brain" artificial intelligence innovation application project, building an intelligent application system covering the entire lifecycle of TCM materials. It focuses on key areas to develop multi-level, multi-scenario intelligent solutions. This suggests that Yunnan is investing in digitalization and AI, which could create demand for tech solutions and smart agriculture technologies.
Practical Guidance for Foreign Founders
Foreign founders looking to register a company or operate in China's TCM sector should consider the following:
- Market Entry: Yunnan's focus on quality and high-value products may create niches for foreign expertise in processing, branding, and technology. However, foreign investment in TCM may be subject to China's Negative List for Foreign Investment Access; consulting local experts is advised.
- Compliance: GAP certification, food-medicine homology standards, and cross-border registration requirements are critical. Ensure your products or services align with these evolving standards.
- Partnerships: Collaborating with local enterprises or research institutions can help navigate the regulatory landscape and access resources.
- Monitoring: Keep an eye on provincial plans like this one, as they often precede regulatory changes and investment incentives.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
Next Steps
Foreign founders interested in exploring opportunities in Yunnan's TCM sector can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.